Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyrimidine nucleoside pool restoration describes therapeutic or physiological interventions aimed at correcting imbalances in intracellular pyrimidine nucleoside or nucleotide concentrations (e.g., dCTP, dTTP), which are critical for DNA replication, genome stability, and cell proliferation. Pool disequilibrium leads to replication stress and genomic instability, which are particularly deleterious in rapidly proliferating tissues and in cancer or certain genetic diseases (e.g., Bloom syndrome). Restoration typically involves modulating enzymes of pyrimidine synthesis or salvage pathways or supplying exogenous nucleosides to achieve balanced de novo and salvage nucleotide synthesis
Enhancing or restoring nucleotide pool balance by modulating nucleotide biosynthesis, salvage, or recycling Preventing accumulation or depletion of specific nucleotide species Alleviating replication stress induced by imbalance
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyrimidine nucleoside pool restoration.